• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情海啸:意大利首例脊髓损伤患者

COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.

作者信息

Righi Gabriele, Del Popolo Giulio

机构信息

Spinal Unit, Careggi University Hospital, Firenze, Italy.

出版信息

Spinal Cord Ser Cases. 2020 Apr 17;6(1):22. doi: 10.1038/s41394-020-0274-9.

DOI:10.1038/s41394-020-0274-9
PMID:32303672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7163165/
Abstract

INTRODUCTION

We present the report of the first, to our best knowledge, case of COVID-19 in a tetraplegic person.

CASE PRESENTATION

A 56-year-old male with AIS A C4 tetraplegia developed fever during the night, without any prodrome. His general practitioner suspected a urinary tract infection and prescribed him antibiotic therapy. After 2 days of antibiotic therapy the fever still persisted, so the individual was admitted to the local hospital and treated with broad-spectrum antibiotics. After 2 days he was transferred to our spinal unit. Considering the worsening of the chest X-ray and fever despite 48 h of broad-spectrum antibiotic therapy, we strongly suspected viral pneumonia. SARS-CoV-2 was detected and antiviral therapy with Lopinavir/Ritonavir, associated with hydroxychloroquine, was promptly started. Fever ceased after 2 days of therapy.

DISCUSSION

Blood test and chest X-ray findings in this patient were similar to previously published findings regarding COVID-19. One difference between this case and the known clinical course of COVID-19 is that did not develop cough. Another interesting feature of our case is that, despite tetraplegia, the clinical course was not severe. Persons with COVID-19 remain asymptomatic, these results underscore the need for rehabilitation and SCI professionals to have a high index of suspicion for COVID-19 in their inpatient and outpatient clients. Only inpatient with fever hase being tested for COVID-19. All new patients are submitted to SARS-COV-2 Test. Moreover, routine testing of patients who have to participate in therapy in common gym areas may be warranted.

摘要

引言

据我们所知,我们报告首例四肢瘫痪患者的新型冠状病毒肺炎病例。

病例介绍

一名56岁男性,患有美国脊髓损伤协会(AIS)A级C4四肢瘫痪,夜间发热,无任何前驱症状。他的全科医生怀疑是尿路感染,并给他开了抗生素治疗。抗生素治疗2天后,发热仍持续,因此该患者被收治到当地医院,接受广谱抗生素治疗。2天后,他被转到我们的脊髓病房。尽管进行了48小时的广谱抗生素治疗,但胸部X光检查结果恶化且仍发热,我们强烈怀疑是病毒性肺炎。检测出新型冠状病毒2(SARS-CoV-2),并立即开始使用洛匹那韦/利托那韦联合羟氯喹进行抗病毒治疗。治疗2天后发热停止。

讨论

该患者的血液检查和胸部X光检查结果与先前发表的关于新型冠状病毒肺炎的结果相似。该病例与已知的新型冠状病毒肺炎临床病程的一个不同之处在于没有出现咳嗽。我们病例的另一个有趣特征是,尽管是四肢瘫痪,但临床病程并不严重。新型冠状病毒肺炎患者可能无症状,这些结果强调康复和脊髓损伤专业人员需要对住院和门诊患者的新型冠状病毒肺炎有高度的怀疑指数。只有发热的住院患者接受了新型冠状病毒肺炎检测。所有新患者都接受了新型冠状病毒2(SARS-CoV-2)检测。此外,对于必须在公共健身房区域参与治疗的患者,可能有必要进行常规检测。

相似文献

1
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.新冠疫情海啸:意大利首例脊髓损伤患者
Spinal Cord Ser Cases. 2020 Apr 17;6(1):22. doi: 10.1038/s41394-020-0274-9.
2
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验(SEV-COVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
3
COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.意大利的 COVID-19 疫情爆发:三位肿瘤患者的临床放射学表现和结果。
J Infect Chemother. 2021 Jan;27(1):99-102. doi: 10.1016/j.jiac.2020.09.008. Epub 2020 Sep 10.
4
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.脊髓损伤患者感染新型冠状病毒肺炎的临床特征与预后:一项病例对照研究
Spinal Cord Ser Cases. 2020 Aug 4;6(1):69. doi: 10.1038/s41394-020-0319-0.
5
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
6
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮,SARS-CoV-2 RNA 阳性复发后成功康复:病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
7
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.干扰素 β1a 对比干扰素 β1b 和常规治疗方案治疗中重度 COVID-19 成人患者的效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.
8
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.肺炎链球菌尿抗原检测对降低 COVID-19 合并感染患者死亡率的有效性:一项临床研究。
Medicina (Kaunas). 2020 Oct 29;56(11):572. doi: 10.3390/medicina56110572.
9
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.评价法维拉韦和干扰素与洛匹那韦/利托那韦和干扰素在 COVID-19 中度患者中的疗效和安全性:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 27;21(1):886. doi: 10.1186/s13063-020-04747-8.
10
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.高剂量干扰素β-1a与低剂量干扰素β-1a(基础治疗方案)相比对中度至重度COVID-19的有益效果研究:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.

引用本文的文献

1
COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised.新型冠状病毒肺炎与脊髓损伤:住院患者的临床表现、临床病程和临床转归。
Spinal Cord Ser Cases. 2024 Feb 13;10(1):5. doi: 10.1038/s41394-024-00617-6.
2
Early insights of the COVID-19 pandemic in the Veterans' Affairs spinal cord injury and disorders population.COVID-19 疫情在退伍军人事务部脊髓损伤和疾病人群中的早期观察结果。
Spinal Cord Ser Cases. 2022 Oct 8;8(1):83. doi: 10.1038/s41394-022-00548-0.
3
Living With Cervical Spinal Cord Injury During the COVID-19 Pandemic: A Qualitative Study.

本文引用的文献

1
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响:系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Early dynamics of transmission and control of COVID-19: a mathematical modelling study.
新冠疫情期间颈脊髓损伤患者的生活:一项定性研究
Arch Rehabil Res Clin Transl. 2022 Sep;4(3):100208. doi: 10.1016/j.arrct.2022.100208. Epub 2022 Jun 11.
4
Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature.COVID-19/SARS-CoV-2 感染在脊髓损伤患者中的临床特征和预后:对现有文献的综述。
Spinal Cord Ser Cases. 2021 Jul 13;7(1):58. doi: 10.1038/s41394-021-00420-7.
5
The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review.《COVID-19 大流行期间的抗生素处方谱:系统文献回顾》。
Microb Drug Resist. 2021 Dec;27(12):1705-1725. doi: 10.1089/mdr.2020.0619. Epub 2021 Jun 1.
6
Hydroxychloroquine: A review of its safety and efficacy in COVID-19.羟氯喹:关于其在2019冠状病毒病中的安全性和疗效的综述
J Family Med Prim Care. 2021 Mar;10(3):1124-1133. doi: 10.4103/jfmpc.jfmpc_1961_20. Epub 2021 Apr 8.
7
Outcomes of patients with COVID-19 after inpatient rehabilitation.COVID-19 患者住院康复后的结果。
PM R. 2022 Feb;14(2):202-209. doi: 10.1002/pmrj.12645. Epub 2021 Jul 29.
8
COVID-19 and spinal cord injury and disease: results of an international survey as the pandemic progresses.COVID-19 与脊髓损伤和疾病:大流行进展期间国际调查的结果。
Spinal Cord Ser Cases. 2021 Feb 12;7(1):13. doi: 10.1038/s41394-020-00356-4.
9
COVID-19 in spinal cord injury patients at a veterans administration hospital: A case series.退伍军人管理局医院脊髓损伤患者的 COVID-19:病例系列。
J Spinal Cord Med. 2022 Sep;45(5):668-680. doi: 10.1080/10790268.2020.1871254. Epub 2021 Jan 19.
10
Initial assessment and management of respiratory infections in persons with spinal cord injuries and disorders in the COVID-19 era.新冠疫情时代脊髓损伤及疾病患者呼吸道感染的初始评估与管理
J Am Coll Emerg Physicians Open. 2020 Oct 24;1(6):1404-1412. doi: 10.1002/emp2.12282. eCollection 2020 Dec.
COVID-19 的传播和控制的早期动态:一项数学建模研究。
Lancet Infect Dis. 2020 May;20(5):553-558. doi: 10.1016/S1473-3099(20)30144-4. Epub 2020 Mar 11.
4
Covid-19 - Navigating the Uncharted.新冠疫情——探索未知领域。
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.
5
Coronavirus Disease 2019 (COVID-19): A Perspective from China.2019 冠状病毒病(COVID-19):来自中国的视角。
Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21.
6
Spinal cord injury and diaphragm neuromotor control.脊髓损伤与膈肌神经运动控制。
Expert Rev Respir Med. 2020 May;14(5):453-464. doi: 10.1080/17476348.2020.1732822. Epub 2020 Feb 25.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection.脊髓损伤后的免疫反应受损会导致控制病毒感染的能力降低。
Exp Neurol. 2010 Nov;226(1):242-53. doi: 10.1016/j.expneurol.2010.08.036. Epub 2010 Sep 9.
9
Altered innate immunity following spinal cord injury.脊髓损伤后先天性免疫的改变。
Spinal Cord. 2008 Jul;46(7):477-81. doi: 10.1038/sc.2008.4. Epub 2008 Feb 12.
10
Central nervous system injury-induced immune deficiency syndrome.中枢神经系统损伤诱导的免疫缺陷综合征
Nat Rev Neurosci. 2005 Oct;6(10):775-86. doi: 10.1038/nrn1765.